oral semaglutide vs subcutaneous semaglutide PDF] Effect of Compared With Placebo and on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial Oral Semaglutide Vs Injectable –

As more individuals face health risks associated with excess weight, the demand for GLP-1 receptor agonist, proven to reduce weight, improve glycemic control and lower cardiometabolic risk, is expected to rise substantially, thereby driving the growth of the GLP-1 receptor agonist market

M-type pyruvate kinase is supportive of anabolic metabolism in cancers, with PKM1 and PKM2 isoforms

Karimzadeh MR, Najmadini A, Azhdari S et al (2025) Association of Alzheimers disease with promoter variations in NPY2R gene

Should metformin remain the first-line therapy for treatment of type 2 diabetes

Trulicity (dulaglutide)

Foods to Avoid or Limit High-fat meals are the single biggest dietary trigger